Get the full Acesion Pharma company profile
Access contacts, investors, buying signals & more
Acesion Pharma, the Danish biotech focused on developing novel drugs for atrial fibrillation, has secured $47.0M in Series b funding. Founded in 2011, the company aims to create more efficacious and safer treatments for AF, the most common type of cardiac arrhythmia.
Its scientific foundation lies in inhibiting SK ion channels, a distinct approach to tackling the condition. This capital will support Acesion Pharma's ongoing work to advance its therapeutic pipeline.
Portfolio company of Canaan
Likvido.dk
Som virksomhedsejer vil du hellere bruge tid på dine kunder og din forretning i stedet for at jagte kunder, der betaler for sent. Likvido gør det nemt og tilgængeligt at administrere debitorer. Vores digitale løsning automatiserer hele din proces fra faktura til betaling. Likvido ApS er en del af Visma. CVR: 43555391
$2.8M Seed
today
LastObject
We are a small dedicated team with a mission to end the need for single use items. Single use items are the main source of marine pollution and costs the earth huge amounts of CO2 and resources every day. Our goal is to create objects that replace single use items. Our first is LastSwab. Our successful Kickstarter campaign for LastSwab, the reusable cotton swab, sold more than 122,000 (as of October 2019). As the first of many new reusable products in the coming years it has become an astounding success.
$1.3M Series a
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 1y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  DrDoctor United Kingdom | Series b | $12.1M | today |
| 2 |  Birdie United Kingdom | Series b | $30.0M | today |
| 3 |
Onomondo
Onomondo is a global cellular operator for the Internet of Things, working to connect and simplify enterprise-grade connected services across the globe. With its innovative network infrastructure implemented globally and operations across over 180 countries, Onomondo enables a more secure, cost-efficient, and scalable connectivity option available. Onomondo is breaking down the barriers to building truly global IoT solutions at scale.
$21.0M Series a
today
| $7.2B |
| 1y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 1y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 1y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 6mo ago |
 By Miles United Kingdom |
| Series b |
| $18.3M |
| today |
| 4 |  WeGift Brazil | Series b | $30.9M | today |
| 5 |  Clean Cult United States | Series b | $5.0M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Acesion Pharma and reach their contacts directly.
Start free trialUnlock 8 more key decision-makers at Acesion Pharma with verified emails and LinkedIn.
Start free trial
Molo
Recently received
BMC Ingredients
Recently received
NxLite
Recently received
